These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16218426)

  • 1. [Impact of metabolic syndrome and diabetes mellitus on cardiovascular events in coronary artery disease without ischemia on stress thallium-201 single photon emission computed tomography after percutaneous coronary intervention].
    Mori T; Ohashi Y; Ejiri J; Takatsuki K; Ichikawa S; Awano K
    J Cardiol; 2005 Sep; 46(3):89-96. PubMed ID: 16218426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of stress cardiac single-photon emission computed tomographic imaging late after percutaneous coronary intervention for assessing cardiac events and time to such events.
    Acampa W; Evangelista L; Petretta M; Liuzzi R; Cuocolo A
    Am J Cardiol; 2007 Aug; 100(3):436-41. PubMed ID: 17659924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome does not predict an increased risk of coronary disease in patients with traditional risk factors referred for stress imaging study.
    Kamalesh M; Campbell S; Ligler L; Meda M; Eckert GJ; Sawada S
    Metab Syndr Relat Disord; 2010 Jun; 8(3):223-8. PubMed ID: 20156076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention.
    Kasai T; Miyauchi K; Kurata T; Okazaki S; Kajimoto K; Kubota N; Daida H
    Hypertens Res; 2008 Feb; 31(2):235-41. PubMed ID: 18360042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
    Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
    Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome and diabetes on a high-risk population with suspected coronary artery disease.
    Timóteo AT; Mota Carmo M; Cruz Ferreira R
    Acta Med Port; 2012; 25(2):83-90. PubMed ID: 22985918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic value of 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting.
    Cottin Y; Rezaizadeh K; Touzery C; Barillot I; Zeller M; Prevot S; L'huillier I; Ressencourt O; André F; Fraison M; Louis P; Brunotte F; Wolf JE
    Am Heart J; 2001 Jun; 141(6):999-1006. PubMed ID: 11376316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.
    Mack MJ; Banning AP; Serruys PW; Morice MC; Taeymans Y; Van Nooten G; Possati G; Crea F; Hood KL; Leadley K; Dawkins KD; Kappetein AP
    Ann Thorac Surg; 2011 Dec; 92(6):2140-6. PubMed ID: 21967819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.
    Marroquin OC; Kip KE; Kelley DE; Johnson BD; Shaw LJ; Bairey Merz CN; Sharaf BL; Pepine CJ; Sopko G; Reis SE;
    Circulation; 2004 Feb; 109(6):714-21. PubMed ID: 14970105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes.
    Marso SP; Mercado N; Maehara A; Weisz G; Mintz GS; McPherson J; Schiele F; Dudek D; Fahy M; Xu K; Lansky A; Templin B; Zhang Z; de Bruyne B; Serruys PW; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S42-52. PubMed ID: 22421230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography: comparison with electrocardiographic and thallium exercise stress test results.
    Kajinami K; Seki H; Takekoshi N; Mabuchi H
    J Am Coll Cardiol; 1995 Nov; 26(5):1209-21. PubMed ID: 7594034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of coronary artery disease using thallium-201 single photon emission computed tomography among patients newly undergoing chronic peritoneal dialysis and its association with mortality.
    Kim SB; Lee SK; Park JS; Moon DH
    Am J Nephrol; 2004; 24(4):448-52. PubMed ID: 15308878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal electron beam computed tomography results: the value of repeating myocardial perfusion single-photon emission computed tomography in the ongoing assessment of coronary artery disease.
    Askew JW; Miller TD; Araoz PA; Breen JF; Hodge DO; Gibbons RJ
    Mayo Clin Proc; 2008 Jan; 83(1):17-22. PubMed ID: 18174005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.
    Berman DS; Hachamovitch R; Kiat H; Cohen I; Cabico JA; Wang FP; Friedman JD; Germano G; Van Train K; Diamond GA
    J Am Coll Cardiol; 1995 Sep; 26(3):639-47. PubMed ID: 7642853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease.
    Yavuz B; Kabakci G; Aksoy H; Tulumen E; Deveci OS; Aytemir K; Tokgozoglu L; Ozkutlu H; Nazli N; Oto A
    Int J Clin Pract; 2008 May; 62(5):717-22. PubMed ID: 18266712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.